|
2026-05-28 |
2026-05-27 |
B
Purchase
|
Non-Executive Director
|
2,815
-43.2%
351.75
US$3,414,053
|
2,815
-43.2%
|
351.75
|
US$3,414,053
|
|
|
2026-05-28 |
2026-05-26 |
B
Purchase
|
Non-Executive Director
|
49,456
-48.4%
59.28
US$2,417,541
|
49,456
-48.4%
|
59.28
|
US$2,417,541
|
|
|
2026-05-28 |
2026-05-22 |
B
Purchase
|
Non-Executive Director
|
9,918
-17.5%
24.73
US$1,270,026
|
9,918
-17.5%
|
24.73
|
US$1,270,026
|
|
|
2026-05-28 |
2026-05-21 |
B
Purchase
|
Non-Executive Director
|
1,000
+22.1%
1.04
US$100,000
|
1,000
+22.1%
|
1.04
|
US$100,000
|
|
|
2026-05-13 |
2026-04-30 |
B
Purchase
|
See Remarks
Executive Director
|
25,000
+1221.9%
1.00
US$25,000
|
25,000
+1221.9%
|
1.00
|
US$25,000
|
|
|
2025-11-18 |
2025-11-14 |
B
Purchase
|
Large shareholder
|
104,183
+12.7%
1.22
US$127,593
|
104,183
+12.7%
|
1.22
|
US$127,593
|
|
|
2025-10-28 |
2025-10-28 |
B
Purchase
|
Large shareholder
|
178,392
+55.5%
1.39
US$247,965
|
178,392
+55.5%
|
1.39
|
US$247,965
|
|
|
2025-10-28 |
2025-10-27 |
B
Purchase
|
Large shareholder
|
4,840
+1.5%
1.37
US$6,625
|
4,840
+1.5%
|
1.37
|
US$6,625
|
|
|
2025-10-28 |
2025-10-27 |
B
Purchase
|
Large shareholder
|
92,642
+12.7%
1.37
US$126,920
|
92,642
+12.7%
|
1.37
|
US$126,920
|
|
|
2025-10-28 |
2025-10-24 |
B
Purchase
|
Large shareholder
|
30,176
+4.3%
1.39
US$41,957
|
30,176
+4.3%
|
1.39
|
US$41,957
|
|
|
2024-12-09 |
2024-12-05 |
B
Purchase
|
President and CEO
Officer
|
161
+inf%
2.25
US$362
|
161
+inf%
|
2.25
|
US$362
|
|
|
2024-12-09 |
2024-12-05 |
B
Purchase
|
President and CEO
Officer
|
239
+inf%
2.24
US$535
|
239
+inf%
|
2.24
|
US$535
|
|
|
2024-06-17 |
2024-06-17 |
S
Sale
|
Large shareholder
|
4,707
-0.3%
3.25
US$15,298
|
4,707
-0.3%
|
3.25
|
US$15,298
|
|
|
2024-06-17 |
2024-06-14 |
S
Sale
|
Large shareholder
|
1,900
-0.1%
3.30
US$6,270
|
1,900
-0.1%
|
3.30
|
US$6,270
|
|
|
2024-06-12 |
2024-06-12 |
S
Sale
|
Large shareholder
|
1
-0.0%
3.28
US$3
|
1
-0.0%
|
3.28
|
US$3
|
|
|
2024-06-12 |
2024-06-12 |
S
Sale
|
Large shareholder
|
9,341
-0.5%
3.25
US$30,358
|
9,341
-0.5%
|
3.25
|
US$30,358
|
|
|
2024-06-12 |
2024-06-11 |
S
Sale
|
Large shareholder
|
502
-0.0%
3.35
US$1,682
|
502
-0.0%
|
3.35
|
US$1,682
|
|
|
2024-06-12 |
2024-06-11 |
S
Sale
|
Large shareholder
|
5,250
-0.3%
3.25
US$17,062
|
5,250
-0.3%
|
3.25
|
US$17,062
|
|
|
2024-06-12 |
2024-06-10 |
S
Sale
|
Large shareholder
|
9,577
-0.5%
3.30
US$31,604
|
9,577
-0.5%
|
3.30
|
US$31,604
|
|
|
2024-06-07 |
2024-06-07 |
S
Sale
|
Large shareholder
|
176
-0.0%
3.30
US$581
|
176
-0.0%
|
3.30
|
US$581
|
|
|
2024-06-07 |
2024-06-07 |
S
Sale
|
Large shareholder
|
1,564
-0.1%
3.25
US$5,083
|
1,564
-0.1%
|
3.25
|
US$5,083
|
|
|
2024-06-07 |
2024-06-06 |
S
Sale
|
Large shareholder
|
3,184
-0.2%
3.30
US$10,507
|
3,184
-0.2%
|
3.30
|
US$10,507
|
|
|
2024-06-07 |
2024-06-06 |
S
Sale
|
Large shareholder
|
1,100
-0.1%
3.27
US$3,597
|
1,100
-0.1%
|
3.27
|
US$3,597
|
|
|
2024-06-07 |
2024-06-05 |
S
Sale
|
Large shareholder
|
6,291
-0.4%
3.30
US$20,760
|
6,291
-0.4%
|
3.30
|
US$20,760
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
25
-0.0%
4.32
US$108
|
25
-0.0%
|
4.32
|
US$108
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
2,903
-0.2%
4.29
US$12,454
|
2,903
-0.2%
|
4.29
|
US$12,454
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
200
-0.0%
4.29
US$857
|
200
-0.0%
|
4.29
|
US$857
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
337
-0.0%
4.28
US$1,442
|
337
-0.0%
|
4.28
|
US$1,442
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
200
-0.0%
4.28
US$855
|
200
-0.0%
|
4.28
|
US$855
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
100
-0.0%
4.27
US$427
|
100
-0.0%
|
4.27
|
US$427
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
317
-0.0%
4.27
US$1,352
|
317
-0.0%
|
4.27
|
US$1,352
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
310
-0.0%
4.26
US$1,321
|
310
-0.0%
|
4.26
|
US$1,321
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
7,923
-0.4%
4.25
US$33,673
|
7,923
-0.4%
|
4.25
|
US$33,673
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
400
-0.0%
4.18
US$1,672
|
400
-0.0%
|
4.18
|
US$1,672
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
670
-0.0%
4.15
US$2,781
|
670
-0.0%
|
4.15
|
US$2,781
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
1,600
-0.1%
4.15
US$6,632
|
1,600
-0.1%
|
4.15
|
US$6,632
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
380
-0.0%
4.13
US$1,569
|
380
-0.0%
|
4.13
|
US$1,569
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
1,750
-0.1%
4.12
US$7,210
|
1,750
-0.1%
|
4.12
|
US$7,210
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
100
-0.0%
4.11
US$411
|
100
-0.0%
|
4.11
|
US$411
|
|
|
2024-05-01 |
2024-05-01 |
S
Sale
|
Large shareholder
|
3,100
-0.2%
4.10
US$12,710
|
3,100
-0.2%
|
4.10
|
US$12,710
|
|
|
2024-05-01 |
2024-04-30 |
S
Sale
|
Large shareholder
|
45
-0.0%
5.00
US$225
|
45
-0.0%
|
5.00
|
US$225
|
|
|
2024-05-01 |
2024-04-30 |
S
Sale
|
Large shareholder
|
45
-0.0%
4.95
US$223
|
45
-0.0%
|
4.95
|
US$223
|
|
|
2024-05-01 |
2024-04-29 |
S
Sale
|
Large shareholder
|
448
-0.0%
5.03
US$2,251
|
448
-0.0%
|
5.03
|
US$2,251
|
|
|
2024-05-01 |
2024-04-29 |
S
Sale
|
Large shareholder
|
13
-0.0%
5.01
US$65
|
13
-0.0%
|
5.01
|
US$65
|
|
|
2024-05-01 |
2024-04-29 |
S
Sale
|
Large shareholder
|
3,231
-0.2%
5.00
US$16,155
|
3,231
-0.2%
|
5.00
|
US$16,155
|
|
|
2024-05-01 |
2024-04-29 |
S
Sale
|
Large shareholder
|
100
-0.0%
4.94
US$494
|
100
-0.0%
|
4.94
|
US$494
|
|
|
2024-05-01 |
2024-04-29 |
S
Sale
|
Large shareholder
|
274
-0.0%
4.93
US$1,351
|
274
-0.0%
|
4.93
|
US$1,351
|
|
|
2024-05-01 |
2024-04-29 |
S
Sale
|
Large shareholder
|
6,680
-0.4%
4.92
US$32,866
|
6,680
-0.4%
|
4.92
|
US$32,866
|
|
|
2024-04-29 |
2024-04-29 |
PrS
Proposed sale
|
10% Stockholder
Large shareholder
|
723,984
5.00
US$3,619,920
|
723,984
|
5.00
|
US$3,619,920
|
|
|
2023-12-18 |
2023-12-15 |
B
Purchase
|
President and COO
Officer
|
225
+inf%
3.37
US$758
|
225
+inf%
|
3.37
|
US$758
|
|
|
2023-11-21 |
2023-11-20 |
B
Purchase
|
President and COO
Officer
|
5,076
+11034.8%
1.97
US$9,987
|
5,076
+11034.8%
|
1.97
|
US$9,987
|
|
|
2021-01-08 |
2021-01-08 |
B
Purchase
|
See Remarks
Executive Director
|
9,000,000
+118.3%
1.10
US$9,900,000
|
9,000,000
+118.3%
|
1.10
|
US$9,900,000
|
|
|
2020-06-17 |
2020-06-15 |
B
Purchase
|
Non-Executive Director
|
5,800
+inf%
1.22
US$7,076
|
5,800
+inf%
|
1.22
|
US$7,076
|
|
|
2020-06-09 |
2020-06-08 |
B
Purchase
|
See Remarks
Non-Executive Director
Large shareholder
|
3,700,000
+94.6%
1.10
US$4,070,000
|
3,700,000
+94.6%
|
1.10
|
US$4,070,000
|
|
|
2020-06-09 |
2020-06-08 |
B
Purchase
|
Non-Executive Director
|
227,272
+104.2%
1.10
US$249,999
|
227,272
+104.2%
|
1.10
|
US$249,999
|
|
|
2019-11-18 |
2019-11-15 |
B
Purchase
|
Bailey Jeffrey Allen
Non-Executive Director
|
39,142
+109.5%
0.51
US$19,962
|
39,142
+109.5%
|
0.51
|
US$19,962
|
|
|
2019-11-18 |
2019-11-14 |
B
Purchase
|
Bailey Jeffrey Allen
Non-Executive Director
|
15,858
+79.7%
0.51
US$8,088
|
15,858
+79.7%
|
0.51
|
US$8,088
|
|
|
2019-11-14 |
2019-11-12 |
B
Purchase
|
|
19,894
+inf%
0.53
US$10,544
|
19,894
+inf%
|
0.53
|
US$10,544
|
|
|
2019-09-16 |
2019-09-13 |
B
Purchase
|
|
25,000
+12.9%
0.97
US$24,255
|
25,000
+12.9%
|
0.97
|
US$24,255
|
|
|
2019-09-16 |
2019-09-12 |
B
Purchase
|
|
88,145
+83.9%
0.98
US$86,250
|
88,145
+83.9%
|
0.98
|
US$86,250
|
|
|
2019-09-05 |
2019-09-04 |
B
Purchase
|
|
23,225
+28.4%
0.71
US$16,583
|
23,225
+28.4%
|
0.71
|
US$16,583
|
|
|
2019-09-04 |
2019-09-03 |
B
Purchase
|
|
13,466
+19.7%
0.70
US$9,428
|
13,466
+19.7%
|
0.70
|
US$9,428
|
|
|
2019-09-04 |
2019-08-30 |
B
Purchase
|
|
15,000
+28.1%
0.73
US$10,968
|
15,000
+28.1%
|
0.73
|
US$10,968
|
|
|
2019-09-03 |
2019-08-29 |
B
Purchase
|
|
3,600
+7.2%
0.77
US$2,771
|
3,600
+7.2%
|
0.77
|
US$2,771
|
|
|
2019-08-20 |
2019-08-16 |
B
Purchase
|
Vukovic Vojo
SVP, Chief Medical Officer
Officer
|
75,000
+inf%
0.59
US$44,452
|
75,000
+inf%
|
0.59
|
US$44,452
|
|
|
2019-08-15 |
2019-08-13 |
B
Purchase
|
Gregory Kathryn
SVP, Chief Business Officer
Officer
|
45,000
+inf%
0.65
US$29,025
|
45,000
+inf%
|
0.65
|
US$29,025
|
|
|
2019-04-02 |
2019-04-01 |
S
Sale
|
Large shareholder
|
20,610
-1.0%
1.90
US$39,159
|
20,610
-1.0%
|
1.90
|
US$39,159
|
|
|
2019-04-02 |
2019-03-29 |
S
Sale
|
Large shareholder
|
106,540
-4.8%
1.85
US$197,099
|
106,540
-4.8%
|
1.85
|
US$197,099
|
|
|
2019-03-15 |
2019-03-15 |
S
Sale
|
Large shareholder
|
43,800
-1.9%
1.92
US$84,096
|
43,800
-1.9%
|
1.92
|
US$84,096
|
|
|
2019-03-15 |
2019-03-14 |
S
Sale
|
Large shareholder
|
13,800
-0.6%
1.88
US$25,944
|
13,800
-0.6%
|
1.88
|
US$25,944
|
|
|
2019-03-15 |
2019-03-13 |
S
Sale
|
Large shareholder
|
132,738
-5.5%
2.12
US$281,405
|
132,738
-5.5%
|
2.12
|
US$281,405
|
|
|
2018-08-22 |
2018-08-20 |
S
Sale
|
Novartis Bioventures Ltd
Large shareholder
|
20,388
-0.8%
2.30
US$46,892
|
20,388
-0.8%
|
2.30
|
US$46,892
|
|
|
2018-08-20 |
2018-08-17 |
S
Sale
|
Novartis Bioventures Ltd
Large shareholder
|
8,700
-0.4%
2.10
US$18,270
|
8,700
-0.4%
|
2.10
|
US$18,270
|
|
|
2018-08-20 |
2018-08-16 |
S
Sale
|
Novartis Bioventures Ltd
Large shareholder
|
8,808
-0.4%
2.10
US$18,497
|
8,808
-0.4%
|
2.10
|
US$18,497
|
|
|
2018-08-16 |
2018-08-15 |
S
Sale
|
Novartis Bioventures Ltd
Large shareholder
|
2,635
-0.1%
2.15
US$5,665
|
2,635
-0.1%
|
2.15
|
US$5,665
|
|